CV5 Capital and Enzyme form a strategic partnership to launch institutional-grade tokenized fund solutions
Foresight News reported that CV5 Capital has announced a strategic partnership with global tokenized financial infrastructure provider Enzyme, which will serve as the foundational technology stack for its tokenized fund issuance and management. CV5 Capital plans to leverage Enzyme Onyx to build, launch, and manage a new generation of investment products, supporting investment strategies across a variety of asset classes including cryptocurrencies, securities, commodities, and US Treasuries.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ripple's Dubai Event Presence Gets High-Profile Boost From Emirates Chairman
Signal of a rebound? Goldman Sachs US stock panic index reaches "extreme levels"
Goldman Sachs Volatility Panic Index surged to 9.57, approaching its maximum value, with the largest single-day increase ranking third in history, and the combined two-day volatility setting a new record. Historical data shows that after this index has exceeded the 9.5 threshold 15 times, the S&P 500 has seen an average three-month gain of 4.6% with a success rate of 80%. However, Goldman Sachs traders warn that forced liquidations have not yet fully cleared, and the market is still searching for a bottom, but opportunities on the other side are becoming increasingly difficult to ignore.
SpaceX (SPCX.US) undergoes board changes: Google executive departs, Tesla merger evaluation underway.
SpaceX (SPCX.US) announced on Friday that Don Harrison has resigned from the company's board of directors.
Crypto prices
More
